STAB Archived Articles
Statera Biopharma (STAB): Building an Innovative Immunotherapy Pipeline to Address Unmet Medical Needs
Published on March 13, 2025
Statera Biopharma, Inc. (STAB): Delivering Groundbreaking Immunotherapies to Transform Patient Outcomes
Published on November 28, 2024
Statera Biopharma, Inc. (NASDAQ:STAB): A Promising Immunotherapy Pipeline Hampered by Financial Challenges
Published on September 24, 2024